Teva Pharmaceutical Industries Limited
NYSE: TEVA
Healthcare
Drug Manufacturers - Specialty & Generic
Israel
Teva Pharmaceutical Industries Limited Stock Split History Overview
This company has undergone a total of three stock splits throughout its history. Three forward splits were executed, enhancing liquidity and increasing share accessibility. The most recent split occurred on 07/01/2004 with a ratio of 2-for-1. If an investor had purchased one share prior to the first split on 02/23/2000, that single share would now have grown to 8 shares. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 07/01/2004 | 2:1 | x2 | x8 | Forward |
| 12/06/2002 | 2:1 | x2 | x4 | Forward |
| 02/23/2000 | 2:1 | x2 | x2 | Forward |
Frequently Asked Questions
If Teva Pharmaceutical Industries Limited (stock symbol: NYSE: TEVA) had never undergone any stock splits, its price per share today would be approximately 136.16 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 2-for-1) that occurred on 07/01/2004.
Teva Pharmaceutical Industries Limited (stock symbol: NYSE: TEVA) has undergone a total of three stock splits. The most recent split occurred on 07/01/2004. One share bought prior to the first split on 02/23/2000 would now equal 8.00 shares.
Teva Pharmaceutical Industries Limited (stock symbol: NYSE: TEVA) has undergone three stock splits in its history. The most recent split, a 2-for-1 split, occurred on 07/01/2004. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
